1. Home
  2. OLMA vs TUSK Comparison

OLMA vs TUSK Comparison

Compare OLMA & TUSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • TUSK
  • Stock Information
  • Founded
  • OLMA 2006
  • TUSK 2014
  • Country
  • OLMA United States
  • TUSK United States
  • Employees
  • OLMA N/A
  • TUSK N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • TUSK Oilfield Services/Equipment
  • Sector
  • OLMA Health Care
  • TUSK Energy
  • Exchange
  • OLMA Nasdaq
  • TUSK Nasdaq
  • Market Cap
  • OLMA 299.7M
  • TUSK 138.6M
  • IPO Year
  • OLMA 2020
  • TUSK 2016
  • Fundamental
  • Price
  • OLMA $4.65
  • TUSK $2.68
  • Analyst Decision
  • OLMA Strong Buy
  • TUSK
  • Analyst Count
  • OLMA 4
  • TUSK 0
  • Target Price
  • OLMA $24.50
  • TUSK N/A
  • AVG Volume (30 Days)
  • OLMA 825.6K
  • TUSK 118.4K
  • Earning Date
  • OLMA 08-05-2025
  • TUSK 08-08-2025
  • Dividend Yield
  • OLMA N/A
  • TUSK N/A
  • EPS Growth
  • OLMA N/A
  • TUSK N/A
  • EPS
  • OLMA N/A
  • TUSK N/A
  • Revenue
  • OLMA N/A
  • TUSK $207,208,000.00
  • Revenue This Year
  • OLMA N/A
  • TUSK N/A
  • Revenue Next Year
  • OLMA N/A
  • TUSK $28.22
  • P/E Ratio
  • OLMA N/A
  • TUSK N/A
  • Revenue Growth
  • OLMA N/A
  • TUSK N/A
  • 52 Week Low
  • OLMA $2.86
  • TUSK $1.68
  • 52 Week High
  • OLMA $16.62
  • TUSK $4.94
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 52.46
  • TUSK 45.69
  • Support Level
  • OLMA $4.38
  • TUSK $2.63
  • Resistance Level
  • OLMA $5.01
  • TUSK $2.72
  • Average True Range (ATR)
  • OLMA 0.30
  • TUSK 0.11
  • MACD
  • OLMA 0.05
  • TUSK -0.04
  • Stochastic Oscillator
  • OLMA 63.64
  • TUSK 10.31

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About TUSK Mammoth Energy Services Inc.

Mammoth Energy Services Inc is an integrated energy services company engaged in providing products and services to enable the exploration and development of North American onshore unconventional oil and natural gas reserves as well as the construction and repair of the electric grid for private utilities, public investor-owned utilities, and co-operative utilities through infrastructure services businesses. The company had three reportable segments, which includes well completion services (Well Completion), infrastructure services (Infrastructure) and natural sand proppant services (Sand). Key revenue is generated from Infrastructure which include electric utility infrastructure services to government-funded utilities, private utilities, public investor-owned utilities, etc.

Share on Social Networks: